Consideration of the risk and treatment of tuberculosis in patients who have rheumatoid arthritis and receive biologic treatments

被引:28
作者
Bieber, J
Kavanaugh, A
机构
[1] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, Dept Med, Sch Med, La Jolla, CA 92037 USA
[2] Univ Calif San Diego, Ctr Innovat Therapy, Sch Med, La Jolla, CA 92093 USA
关键词
D O I
10.1016/j.rdc.2004.01.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Evidence supports the association of tuberculosis (TB) with tumor necrosis factor inhibitor therapy in patients who have rheumatoid arthritis. There seem to be differential risks of TB with the currently available inhibitors. Screening for latent TB infection with purified protein derivative is indicated for patients who are being considered for treatment; it seems to be effective in reducing the occurrence of TB in treated patients.
引用
收藏
页码:257 / +
页数:15
相关论文
共 67 条
  • [1] *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_
  • [2] Specific immune-based diagnosis of tuberculosis
    Andersen, P
    Munk, ME
    Pollock, JM
    Doherty, TM
    [J]. LANCET, 2000, 356 (9235) : 1099 - 1104
  • [3] Benini J, 1999, J PATHOL, V189, P127, DOI 10.1002/(SICI)1096-9896(199909)189:1<127::AID-PATH398>3.0.CO
  • [4] 2-S
  • [5] Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFα receptors
    Berg, L
    Lampa, J
    Rogberg, S
    van Vollenhoven, R
    Klareskog, L
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (02) : 133 - 139
  • [6] BIEBER J, 2003, ANN RHEUM DIS MAYO C, V78, P436
  • [7] Late reactivation of spinal tuberculosis by low-dose methotrexate therapy in a patient with rheumatoid arthritis
    Binymin, K
    Cooper, RG
    [J]. RHEUMATOLOGY, 2001, 40 (03) : 341 - 342
  • [8] Bopst M, 2001, EUR J IMMUNOL, V31, P1935, DOI 10.1002/1521-4141(200106)31:6&lt
  • [9] 1935::AID-IMMU1935&gt
  • [10] 3.0.CO